Outcomes in Resected Melanoma Influenced by Timing of Recurrence

Published Date: 12 Aug 2024

Early recurrence after anti-PD-1/L1 likely to benefit more from anti-CTLA-4, targeted agents

Read Full News

Latest News


News All Time

HTTP error: 503 HTTP error: 503 HTTP error: 503HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot